ERAS - Financial Reports List - Erasca, Inc. - IntrinsicAlpha

Erasca, Inc. ERAS

Healthcare - Biotechnology - NASDAQ - US

$ 1.21

-4.69 %

$ 343 M

Market Cap

-2.14

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	11.57%	8.29%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-8.52%	-5.43%
Annual Report	FY	10-K	2024-12-31	0.00%	-29.28%	-26.89%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-2.76%	-7.46%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-98.86%	-25.89%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-19.21%	-4.93%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	77.51%	-55.54%
Annual Report	FY	10-K	2023-12-31	0.00%	47.50%	42.81%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	12.55%	6.23%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	10.00%	-0.18%

1